Immudex ApS

Immudex is a life sciences reagent manufacturer specializing in flow cytometry and immune cell analysis tools for research and clinical applications. The company develops and supplies Dextramer® technology products—multimeric MHC-peptide complexes—for detection and characterization of antigen-specific T cells, B cells, non-conventional T cells, and CAR-T cells. Core product lines include MHC I and II Dextramers for flow cytometry, custom MHC allele solutions, disease-specific panels (infectious disease, autoimmunity, immuno-oncology), Klickmer® technology for next-generation sequencing and multi-omics applications, and Xynapse™ reagents for T cell activation and stimulation. The company also offers GMP-grade Dextramer® and MHC monomer reagents for clinical lot-release testing of cell therapies, supporting development of TCR-T and CAR-T immunotherapies. Immudex provides custom services including custom alleles, TCR discovery solutions, pMHC binding screening, and CAR Dextramer® development. Applications span vaccine development, cell therapy characterization, infectious disease monitoring, transplantation immune surveillance, and antibody discovery. Products are used in both academic research and pharmaceutical/biotech development. The company maintains headquarters in Virum, Denmark and a US corporate office in Fairfax, Virginia, with a visiting location in Philadelphia.